Paediatrics Publications
Document Type
Conference Proceeding
Publication Date
10-1-2020
Journal
The Journal of rheumatology
Volume
47
Issue
10
First Page
1584
Last Page
1586
URL with Digital Object Identifier
https://doi.org/10.3899/jrheum.200480
Abstract
The Canadian Inflammatory Myopathy Study (CIMS) is a multicenter prospective cohort recruiting in 8 centers across Canada. One of the aims of CIMS is to conduct and participate in clinical trials in autoimmune inflammatory myopathies (AIM). Conducting clinical trials in rare diseases such as AIM presents challenges. During this symposium, experts in the field presented different solutions to successfully conduct clinical trials in AIM, including the importance of collaboration and careful trial design, as well as training and mentoring of young investigators.
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License